WuXi Biologics, a leading global biologics medicine manufacturer, is to invest €325 million in a new biopharmaceuticals contract manufacturing facility in Dundalk, Co. Louth. Located mid-way between Dublin and Belfast, the facility will be less than an hour’s drive from Ireland’s two largest cities.
This highly significant investment will provide a valuable employment boost for the region, leading to the creation of 400 jobs when in full production (Scheduled for 2021). The jobs at the facility will range from manufacturing to technical and quality assurance roles as well as associated administration positions. When complete, WuXi Biologics Ireland will be the world’s largest facility using single-use bioreactor technology.